Pourquier P - Search Results

1

Doxorubicin-induced lipid peroxidation and glutathione peroxidase activity in tumor cell lines selected for resistance to doxorubicin.

Benchekroun MN, Pourquier P, Schott B, Robert J. Benchekroun MN, et al. Among authors: pourquier p. Eur J Biochem. 1993 Jan 15;211(1-2):141-6. doi: 10.1111/j.1432-1033.1993.tb19880.x. Eur J Biochem. 1993. PMID: 8425524 Free article.

2

Differential over-expression of mdr1 genes in multidrug-resistant rat glioblastoma cell lines selected with doxorubicin or vincristine.

Schott B, Bennis S, Pourquier P, Ries C, Londos-Gagliardi D, Robert J. Schott B, et al. Among authors: pourquier p. Int J Cancer. 1993 Aug 19;55(1):115-21. doi: 10.1002/ijc.2910550121. Int J Cancer. 1993. PMID: 8102127

3

Differential stabilization of topoisomerase-II-DNA cleavable complexes by doxorubicin and etoposide in doxorubicin-resistant rat glioblastoma cells.

Montaudon D, Pourquier P, Denois F, de Tinguy-Moreaud E, Lagarde P, Robert J. Montaudon D, et al. Among authors: pourquier p. Eur J Biochem. 1997 Apr 15;245(2):307-15. doi: 10.1111/j.1432-1033.1997.00307.x. Eur J Biochem. 1997. PMID: 9151958 Free article.

4

Cyclosporin A, verapamil and S9788 reverse doxorubicin resistance in a human medullary thyroid carcinoma cell line.

Massart C, Gibassier J, Raoul M, Pourquier P, Leclech G, Robert J, Lucas C. Massart C, et al. Among authors: pourquier p. Anticancer Drugs. 1995 Feb;6(1):135-46. doi: 10.1097/00001813-199502000-00016. Anticancer Drugs. 1995. PMID: 7756676

5

Relationships between DNA damage and growth inhibition induced by topoisomerase II-interfering drugs in doxorubicin-sensitive and -resistant rat glioblastoma cells.

de Tinguy-Moreaud E, Pourquier P, Montaudon D, Robert J. de Tinguy-Moreaud E, et al. Among authors: pourquier p. Anticancer Res. 1994 Jan-Feb;14(1A):99-103. Anticancer Res. 1994. PMID: 8166463

6

Effects of modulators of multidrug resistance on the expression of the MDR1 gene on human KB cells in culture.

Hu YP, Pourquier P, Doignon F, Crouzet M, Robert J. Hu YP, et al. Among authors: pourquier p. Anticancer Drugs. 1996 Sep;7(7):738-44. doi: 10.1097/00001813-199609000-00004. Anticancer Drugs. 1996. PMID: 8949984

7

Transcriptional down-regulation of c-myc expression in an erythroleukemic cell line, K562, and its doxorubicin-resistant variant by two topoisomerase II inhibitors, doxorubicin and amsacrine.

Clary A, Larrue A, Pourquier P, Robert J. Clary A, et al. Among authors: pourquier p. Anticancer Drugs. 1998 Mar;9(3):245-54. doi: 10.1097/00001813-199803000-00007. Anticancer Drugs. 1998. PMID: 9625435

8

Doxorubicin-induced alterations of c-myc and c-jun gene expression in rat glioblastoma cells: role of c-jun in drug resistance and cell death.

Pourquier P, Montaudon D, Huet S, Larrue A, Clary A, Robert J. Pourquier P, et al. Biochem Pharmacol. 1998 Jun 15;55(12):1963-71. doi: 10.1016/s0006-2952(98)00006-9. Biochem Pharmacol. 1998. PMID: 9714316

9

Predicting drug response based on gene expression.

Robert J, Vekris A, Pourquier P, Bonnet J. Robert J, et al. Among authors: pourquier p. Crit Rev Oncol Hematol. 2004 Sep;51(3):205-27. doi: 10.1016/j.critrevonc.2004.06.002. Crit Rev Oncol Hematol. 2004. PMID: 15331079 Review.

10

[Expression of the MDR1 gene in five human cell lines of medullary thyroid cancer and reversion of the resistance to doxorubicine by ciclosporin A and verapamil].

Massart C, Gibassier J, Lucas C, Pourquier P, Robert J. Massart C, et al. Among authors: pourquier p. Bull Cancer. 1996 Jan;83(1):39-45. Bull Cancer. 1996. PMID: 8672855 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters